Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Flexion Therapeutics Inc (Flexion) discovers, develops and commercializes pain therapies. The company's pipeline is focused on indications that include osteoarthritis knee pain, OA pain, disease modification, and acute-post operative pain. The company’s marketed product includes Zilretta which is the first and only extended-release, intra-articular therapy for patients facing with osteoarthritis-related knee pains. Flexion employs its proprietary microsphere technology to combine triamcinolone acetonide (TA) with a polylactic-co-glycolic acid (PLGA) matrix for formulating Zilretta. Its pipeline product candidate FX201 is being developed for treating pain caused from osteoarthritis of the knee and FX301, a NaV1.7 inhibitor in preclinical phase indicated for the treatment of acute-post operative pain. The company markets Zilretta in the US through its own sales and marketing organization and distributors. Flexion is headquartered in Burlington, Massachusetts, the US.
Oct 12, 2021: Pacira to acquire Flexion Therapeutics to boost non-opioid pain portfolio
Oct 01, 2021: Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 04, 2021: Flexion Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
Jul 29, 2021: Flexion Therapeutics to Report Second-Quarter 2021 Financial Results on August 4, 2021
Jul 12, 2021: Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors
You get detailed information about the company and its operations to identify potential customers and suppliers.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Gain key insights into the company for academic or business research.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Flexion Therapeutics Inc (Flexion) discovers, develops and commercializes pain therapies. The company's pipeline is focused on indications that include osteoarthritis knee pain, OA pain, disease modification, and acute-post operative pain. The company’s marketed product includes Zilretta which is the first and only extended-release, intra-articular therapy for patients facing with osteoarthritis-related knee pains. Flexion employs its proprietary microsphere technology to combine triamcinolone acetonide (TA) with a polylactic-co-glycolic acid (PLGA) matrix for formulating Zilretta. Its pipeline product candidate FX201 is being developed for treating pain caused from osteoarthritis of the knee and FX301, a NaV1.7 inhibitor in preclinical phase indicated for the treatment of acute-post operative pain. The company markets Zilretta in the US through its own sales and marketing organization and distributors. Flexion is headquartered in Burlington, Massachusetts, the US.
Flexion Therapeutics Inc Key Recent Developments
Oct 12, 2021: Pacira to acquire Flexion Therapeutics to boost non-opioid pain portfolio
Oct 01, 2021: Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 04, 2021: Flexion Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
Jul 29, 2021: Flexion Therapeutics to Report Second-Quarter 2021 Financial Results on August 4, 2021
Jul 12, 2021: Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company- Flexion Therapeutics Inc - Key Facts
- Flexion Therapeutics Inc - Key Employees
- Flexion Therapeutics Inc - Key Employee Biographies
- Flexion Therapeutics Inc - Major Products and Services
- Flexion Therapeutics Inc - History
- Flexion Therapeutics Inc - Company Statement
- Flexion Therapeutics Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Flexion Therapeutics Inc - Business Description
- Flexion Therapeutics Inc - Corporate Strategy
- Flexion Therapeutics Inc - SWOT Analysis
- SWOT Analysis - Overview
- Flexion Therapeutics Inc - Strengths
- Flexion Therapeutics Inc - Weaknesses
- Flexion Therapeutics Inc - Opportunities
- Flexion Therapeutics Inc - Threats
- Flexion Therapeutics Inc - Key Competitors
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
- Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
- Flexion Therapeutics Inc, Recent Deals Summary
- Aug 04, 2021: Flexion Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
- Jul 29, 2021: Flexion Therapeutics to Report Second-Quarter 2021 Financial Results on August 4, 2021
- Jul 12, 2021: Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors
- Jun 14, 2021: Flexion Therapeutics to Present at the 2021 Raymond James Human Health Innovation Conference
- Jun 09, 2021: Flexion Therapeutics Announces Appointment of William T. Andrews M.D., F.A.C.P. as Chief Medical Officer
- Jun 09, 2021: Flexion Therapeutics Announces Appointment of William T. Andrews, M.D., F.A.C.P., as Chief Medical Officer
- Jun 02, 2021: Flexion Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference
- May 13, 2021: Flexion Therapeutics to Present at the RBC Capital Markets 2021 Virtual Global Healthcare Conference
- May 12, 2021: Flexion Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Updates
- May 05, 2021: Flexion Therapeutics to Report First-Quarter 2021 Financial Results on May 12, 2021
- Methodology
- Ratio Definitions
- About the Publisher
List of Tables
- Flexion Therapeutics Inc, Key Facts
- Flexion Therapeutics Inc, Key Employees
- Flexion Therapeutics Inc, Key Employee Biographies
- Flexion Therapeutics Inc, Major Products and Services
- Flexion Therapeutics Inc, History
- Flexion Therapeutics Inc, Subsidiaries
- Flexion Therapeutics Inc, Key Competitors
- Flexion Therapeutics Inc, Ratios based on current share price
- Flexion Therapeutics Inc, Annual Ratios
- Flexion Therapeutics Inc, Interim Ratios
- Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
- Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
- Flexion Therapeutics Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
List of Figures
- Flexion Therapeutics Inc, Performance Chart (2016 - 2020)
- Flexion Therapeutics Inc, Ratio Charts
- Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
- Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Centrexion Therapeutics Corp
- Ampio Pharmaceuticals Inc
- Regeneron Pharmaceuticals Inc
- Avanos Medical Inc
- New York R&D Center for Translational Medicine and Therapeutics Inc
- Bionpharma Inc
- Anika Therapeutics Inc
- Teligent Inc
